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Mobile group II introns are bacterial retrotransposons that combine the activities of an autocatalytic intron RNA
(a ribozyme) and an intron-encoded reverse transcriptase to insert site-specifically into DNA. They recognize DNA
target sites largely by base pairing of sequences within the intron RNA and achieve high DNA target specificity by
using the ribozyme active site to couple correct base pairing to RNA-catalyzed intron integration. Algorithms have
been developed to program the DNA target site specificity of several mobile group II introns, allowing them to be
made into ‘targetrons.’ Targetrons function for gene targeting in a wide variety of bacteria and typically integrate at
efficiencies high enough to be screened easily by colony PCR, without the need for selectable markers. Targetrons
have found wide application in microbiological research, enabling gene targeting and genetic engineering of
bacteria that had been intractable to other methods. Recently, a thermostable targetron has been developed for
use in bacterial thermophiles, and new methods have been developed for using targetrons to position recombinase
recognition sites, enabling large-scale genome-editing operations, such as deletions, inversions, insertions, and
‘cut-and-pastes’ (that is, translocation of large DNA segments), in a wide range of bacteria at high efficiency. Using
targetrons in eukaryotes presents challenges due to the difficulties of nuclear localization and sub-optimal magnesium
concentrations, although supplementation with magnesium can increase integration efficiency, and directed evolution
is being employed to overcome these barriers. Finally, spurred by new methods for expressing group II intron reverse
transcriptases that yield large amounts of highly active protein, thermostable group II intron reverse transcriptases
from bacterial thermophiles are being used as research tools for a variety of applications, including qRT-PCR and
next-generation RNA sequencing (RNA-seq). The high processivity and fidelity of group II intron reverse transcriptases
along with their novel template-switching activity, which can directly link RNA-seq adaptor sequences to cDNAs during
reverse transcription, open new approaches for RNA-seq and the identification and profiling of non-coding RNAs, with
potentially wide applications in research and biotechnology.
Keywords: Genome engineering, Metabolic engineering, Next-generation RNA sequencing, Ribozyme, Synthetic
biology, Systems biology, TargetronReview
Introduction
Mobile group II introns are bacterial retrotransposons that
perform a remarkable ribozyme-based, site-specific DNA
integration reaction (‘retrohoming’) and encode an equally
remarkable reverse transcriptase (RT), both of which have
been harnessed for biotechnological applications [1-3].* Correspondence: lambowitz@austin.utexas.edu
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stated.Retrohoming occurs by a mechanism in which the group
II intron RNA uses its ribozyme activity to insert directly
into a DNA strand, where it is reverse transcribed by the
intron-encoded RT (also referred to as the intron-encoded
protein or IEP), yielding a cDNA copy of the intron that is
integrated into the genome [4]. Because mobile group II
introns recognize DNA target sequences largely by base
pairing of sequence motifs within the intron RNA, they
can be programmed to insert into desired DNA sites by
simply modifying the intron sequences so as to base pair
to the new target site. This feature allows mobile group IILtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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trons’, which combine high DNA integration efficiency
with readily programmable and reliable DNA target speci-
ficity [5-7]. Targetrons are widely used for genetic engin-
eering of bacteria, and efforts continue to adapt them for
function in eukaryotes.
Group II intron RTs function in retrohoming by syn-
thesizing a full-length cDNA of the highly structured in-
tron RNA with high processivity and fidelity [8-10],
properties that are useful for biotechnological applica-
tions involving cDNA synthesis, such as qRT-PCR and
next-generation RNA sequencing (RNA-seq). The RTs
also have a novel template-switching activity that enables
facile attachment of adaptor sequences containing primer-
binding sites and barcodes to cDNAs. These properties,
combined with the availability of naturally occurring ther-
mostable group II intron RTs [11,12] open new ap-
proaches for RNA-seq and the profiling and discovery of
miRNAs and other non-coding RNAs [10,13].
Here, we describe how the novel biochemical activities
of mobile group II introns and their RTs, which were
acquired during the evolution of group II introns as mo-
bile genetic elements, have been adapted for biotech-
nological applications. We then review how group II
intron-derived targetrons have been used for the genetic
engineering of diverse bacteria, as well as recent ad-
vances in targetron technology. The latter include the
development of a thermotargetron for gene targeting in
thermophiles, methods for using targetrons to position
recombinase recognition sites for large-scale genomeA B
Figure 1 Group II intron RNA structure and splicing mechanism. (A) G
Lactococcus lactis Ll.LtrB group IIA intron. Intron RNA domains are different
dark and light blue lines, respectively. The large ‘loop’ region of DIV, which
drawn to scale. (B) Crystal structure of the Oceanobacillus iheyensis group II
from Protein Data Bank file 3IGI [20] (www.pdb.org) with PyMol. Group II in
splicing and reverse splicing. Double-stranded DNA is indicated by double
blue, respectively; the intron and intron RNA are shown in red; and the intrearrangements, and progress in developing targetrons
for gene targeting in eukaryotes. Finally, we discuss the
development of thermostable group II intron RTs from
bacterial thermophiles as new tools for cDNA synthe-
sis, with potentially wide applications in research and
biotechnology.
Mobile group II introns
Mobile group II introns are found in bacteria, archaea,
and the mitochondrial and chloroplast DNAs of some
eukaryotes, and are thought to be evolutionary ancestors
of spliceosomal introns, the spliceosome, retrotranspo-
sons, and retroviruses in higher organisms [3,14,15].
They are especially prevalent and widespread in bacteria,
with hundreds of bacterial group II introns having been
identified by genome sequencing [16].
Mobile group II introns consist of a catalytically active in-
tron RNA, which encodes an RT (Figure 1) [1-3,17]. Group
II intron RNAs have a length of 400 to 800 nts, excluding
the ORF encoding the RT [3]. They have little sequence
similarity to each other, but fold into a conserved three-
dimensional structure consisting of six interacting double
helical domains (DI-DVI) (Figure 1A and B) [17-21].
The folded group II intron RNA contains an active site
that uses specifically bound Mg2+ ions to catalyze RNA
splicing via two sequential transesterification reactions
that yield ligated exons and an excised intron lariat
RNA, the same reaction mechanism used for the splicing
of nuclear spliceosomal introns in eukaryotes (Figure 1C)
[1]. Because the transesterification reactions used forC
roup II intron RNA secondary structure. The example shown is the
colors, and the 5’ and 3’ exons (E1 and E2, respectively) are thicker
encodes the group II intron RT, is shown as a dashed line and not
C intron. The ribbon diagram of the intron’s structure was generated
tron RNA domains are colored as in panel A. (C) Group II intron RNA
lines and RNA as a single line. E1 and E2 are shown in dark and light
ron-encoded RT is shown in green.
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reverse splicing of the intron into RNA or DNA sites
containing the ligated exon sequence, with reverse spli-
cing into DNA playing a key role in intron mobility.
Both steps of reverse splicing (referred to as complete
reverse splicing) result in the insertion of the excised in-
tron RNA between the 5’ and 3’ exons, while the first
step (referred to as partial reverse splicing) results in the
attachment of the 3’ end of the intron RNA to the 5’ end
of the downstream exon, leaving a strand break.
Some key regions of group II intron RNAs are DI, which
contains the motifs that base pair with the DNA target
site; DIV, which contains the ORF encoding the RT; DV, a
metal-ion-binding domain that comprises most of the
active site; and DVI, which contains the branch-point
nucleotide [19]. Three subclasses of group II introns,
denoted IIA, IIB, and IIC, have been distinguished by vari-
ations of the conserved RNA structure [3]. Crystal struc-
tures of a group IIC intron at different stages of reaction
have been determined, providing insight into the nature of
the active site and the mechanisms of RNA splicing and
reverse splicing (Figure 1B) [19-21].
Group II intron RTs typically consist of 400 to 600
amino acids and contain a series of conserved motifs
characteristic of retroviral and other RTs [3]. Figure 2
shows schematics of several group II intron RTs that are
discussed in this review. Group II intron RTs contain con-
served N-terminal RT and X domains, which correspondA
B
Figure 2 Group II intron reverse transcriptases (RTs). (A) Group
II intron RTs encoded by the L. lactis Ll.LtrB, E. coli EcI5, and
Sinorhizobium meliloti RmInt1 introns, which have been converted
into targetrons. The Ll.LtrB RT is also referred to as the LtrA protein.
(B) Thermostable group II intron RTs from bacterial thermophiles
used for biotechnological applications involving cDNA synthesis, such
as qRT-PCR, RNA-seq, and miRNA profiling. Group II intron domains are:
RT, with conserved RT sequence blocks 1 to 7 found in all RTs (black
rectangles) and additional conserved regions RT-0 and RT-2a also
found in non-LTR-retrotransposon RTs [23]; X/thumb, white hatching;
DNA binding (D), horizontal black lines; DNA endonuclease (En),
black dots.to the fingers/palm and thumb domains of retroviral RTs,
respectively. In addition to reverse transcription, the RT
and X domains bind specifically to the intron RNA to
stabilize the active ribozyme structure for RNA splicing
and reverse splicing (referred to as ‘maturase’ activity,
an example of protein-assisted RNA catalysis). Group II
intron RTs lack an RNase H domain, but typically have
C-terminal DNA-binding (D) and DNA endonuclease
(En) domains that interact with DNA target sites during
retrohoming. Some IEPs, such as that encoded by RmInt1
from Sinorhizobium meliloti [22] (Figure 2A), lack the En
domain. Notably, the RT and thumb domains of group
II intron RTs are larger than those of retroviral RTs and
contain an N-terminal extension and several distinctive
‘insertions’ between the conserved RT sequence blocks
[23]. The larger RT and thumb domains may enable
more extensive interactions with RNA templates and
thus contribute to the high processivity of group II
intron RTs (see below).
Group II intron retrohoming
Group II intron retrohoming has been reviewed in detail
elsewhere [3,4], and here we describe only the major
steps and variations pertinent to the mechanism of gene
targeting. As shown in Figure 3, retrohoming starts with
the group II intron splicing out of a larger RNA mol-
ecule, typically a transcript of the gene in which the
group II intron is inserted. Splicing is accomplished via
folding of the intron RNA into a catalytic structure, with
help of the RT, which binds the intron RNA and stabi-
lizes the active RNA tertiary structure. As discussed
above, splicing occurs via two transesterification reac-
tions that yield ligated exons and an excised intron
lariat. After splicing, the RT remains tightly bound to
the excised intron lariat RNA in a ribonucleoprotein
(RNP) complex that initiates retrohoming by recognizing
DNA target sequences by a combination of site-specific
binding of the RT and base pairing of sequence motifs in
the intron RNA, described in detailed below. The intron
RNA then integrates directly into the DNA target site by
full reverse splicing (see above), while the endonuclease
activity of the RT cuts the opposite DNA strand slightly
downstream of the insertion site, leaving an overhang
with a cleaved 3’ end that is used as a primer for synthe-
sis of a cDNA copy of the inserted intron RNA by the
RT [24-26]. Introns encoding RTs lacking the endo-
nuclease activity retrohome by using nascent lagging or
leading DNA strands at DNA replication forks as pri-
mers for reverse transcription [27-29].
The cDNA copy of the reverse-spliced intron RNA is
integrated into the host genome by common cellular
DNA recombination or repair mechanisms, a feature
that contributes to the wide host range of group II in-
trons. Recent findings have further elucidated late steps
Figure 3 Group II intron retrohoming. In the first step, the reverse transcriptase (RT) binds to the intron in a larger initial transcript of a gene
and promotes RNA splicing, resulting in a ribonucleoprotein (RNP) complex that contains the excised intron lariat RNA and the tightly bound RT.
RNPs recognize DNA target sites by using both the RT and base pairing of the intron RNA and then promote reverse splicing of the intron RNA
into the top strand of the double-stranded DNA. After reverse splicing, the bottom DNA strand is cleaved by the En domain of the RT, and the 3’
end generated at the cleavage site is used as a primer for target DNA-primed reverse transcription of the inserted intron RNA. The resulting intron
cDNA (black) is integrated into the host genome by cellular DNA recombination or repair mechanisms.
Enyeart et al. Mobile DNA 2014, 5:2 Page 4 of 19
http://www.mobilednajournal.com/content/5/1/2in group II intron integration in Escherichia coli, in which
a cellular RNase H degrades the intron RNA, and replica-
tion restart proteins then recruit the host replicative DNA
polymerase, which synthesizes DNA corresponding to the
sense strand of the intron [30]. Host nucleases trim DNA
overhangs, and ligases repair remaining nicks [31].
Some group II introns splice via hydrolysis rather than
branching and thus excise a linear rather than a lariat
intron RNA [32,33]. During retrohoming, linear group II
intron RNAs can carry out only the first step of reverse
splicing, attaching the 3’ end of the linear intron to the
downstream DNA exon, which, combined with En cleav-
age of the opposite strand, yields a double-strand break
that can be repaired by homologous recombination with
exogenous DNA [34]. This double-strand break-stimulated
recombination provides an alternative gene targeting me-
chanism for group II introns, analogous to that used byZn-finger nucleases, TALENs, and CRISPR-based sys-
tems [35]. In some hosts, the linear group II intron
RNA inserted at a target site is reverse-transcribed to
yield a cDNA that can be integrated into the genome by
non-homologous end joining [36,37].
DNA-target site recognition
The key to using group II introns for gene targeting is
their mode of DNA target site recognition. Group II in-
tron RNPs recognize DNA target sequences by using
both the RT and base pairing of the intron RNA, with
the latter contributing most of the DNA target specifi-
city [5,38]. Group IIA, IIB, and IIC introns differ some-
what in how they recognize DNA target sites, and these
differences impact design and performance in the bio-
technological context. The major target site interactions
for the Lactococcus lactis Ll.LtrB intron, the most widely
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trons used as targetrons are illustrated in Figure 4.
In group IIA introns, like the Ll.LtrB intron, the intron
RNA contains three sequence motifs in DI that recognize
DNA target sites by base pairing. These are denoted
EBS1, EBS2, and δ, and they base pair to complemen-
tary sequences in the DNA target site denoted IBS1,
IBS2, and δ’ (where EBS stands for ‘exon-binding site’
and IBS stands for ‘intron-binding site’; these same in-
teractions also occur upon splicing out of a larger RNA
molecule). The Ll.LtrB RT (denoted LtrA protein) rec-
ognizes nucleotides both upstream and downstream of
the IBS/δ’ sequences (colored purple and blue, respect-
ively, in Figure 4). Binding of the RT promotes DNA
melting [39], enabling the intron RNA to base pair to
the DNA target sequence, and DNA bending, which po-
sitions the target DNA properly for cleavage and prim-
ing of reverse transcription [40].
Group IIB introns, like EcI5 and RmInt1, also contain
three sequence elements that recognize the DNA targetFigure 4 DNA target site recognition by mobile group II
introns. The figure shows DNA target-site interactions for the Ll.LtrB
group IIA intron and the EcI5 and RmInt1 group IIB introns used as
targetrons. Portions of the intron RNA involved in the EBS1-IBS1,
EBS2-IBS2, and δ − δ’ or EBS3-IBS3 base-pairing interactions with the
DNA target site are shown in red. Purple and blue highlights indicate
base-pairs in the 5’ and 3’ exons (E1 and E2, respectively) that are
important for DNA targeting and recognized by the reverse transcriptase
(RT). CS, bottom-strand cleavage site; IS, intron-insertion site.site by base pairing. Specifically, EBS1, EBS2, and EBS3
base pair to corresponding IBS sequences in the target.
The EBS3 sequence is located in a different part of the
DI structure than the corresponding δ sequence in
group IIA introns [41]. The RT again recognizes flanking
sequences. In EcI5, a relatively well-studied example of
this class [42], the RT recognizes a similar number of
residues as the RT of Ll.LtrB, although the identities and
locations of these residues differ. RmInt1, whose RT
lacks the En domain, inserts into the single-stranded
DNA formed during replication and thus has no require-
ment for DNA melting [28]. The RmInt1 RT recognizes
only two critical nucleotide residues, but additional
sequences may contribute [43].
Group IIC introns recognize short IBS1 and IBS3 se-
quences. A DNA hairpin, such as those found in gene
terminators or phage attachment sites, is also a key rec-
ognition determinant and seems to take the place of the
IBS2 sequence for these introns, although the mechan-
ism of recognition is as yet unknown [44-46]. Group IIC
introns can thus integrate into multiple sites, and speci-
ficity is limited.
Group IIA and IIB introns have high DNA-target
specificity and integrate only rarely into ectopic sites
(for example, retrotransposition of the Ll.LtrB intron
into ectopic sites in the E. coli chromosome occurs at a
frequency of 0.1 to 30 × 10-6) [3,47]. This high specifi-
city reflects, in part, the fact that group II introns use
both the RT and base pairing of the intron RNA to
recognize their DNA target sequences, with the RTs of
the Ll.LtrB and EcI5 introns most stringently recogniz-
ing 4 to 5 nts and intron RNA base pairing extending
over 11 to 14 nts spanning the intron-insertion site.
Additionally, because the heteroduplex between the
intron RNA and DNA target strand must bind to the
intron RNA’s active site for reverse splicing, mis-
matches in base pairing strongly affect the kcat as well
as Km of the targeting reaction, providing greater dis-
crimination against mispairings than can be obtained
by binding affinity alone [48].
This intertwining of DNA target binding and catalysis
differs from CRISPR-based systems, which have been
used in bacteria and eukaryotes and also rely on base-
pairing between RNA and DNA to provide specificity
[49-55]. CRISPR systems use a guide RNA bound by
a protein endonuclease (Cas9 being the canonical ex-
ample) and can in theory target any stretch of twenty
base pairs that is followed by a specific ‘protospacer
adjacent motif ’ (PAM), which in currently utilized sys-
tems is a stretch of two to five nts recognized by the
endonuclease. However, the guide RNA does not play a
catalytic role and thus specificity appears to be governed
solely by its binding affinity to the DNA target site, with
the protein endonuclease cutting anytime the RNA/
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Indeed, concerns have been raised about the high off-
targeting rate of these systems, with off-target sites
having up to five mismatches found to be targeted at ef-
ficiencies similar to the intended site [56]. A further
limitation for wide use in bacteria is that, unlike group II
introns, CRISPR-based systems function only to introduce
a double-strand break, and integration of exogenous DNA
at the break site is dependent upon homologous re-
combination at a higher efficiency than is found in most
bacterial species [53].
Targetrons
Because mobile group II introns recognize their DNA
target sites by a combination of base-pairing interactions
and site-specific binding of the RT, the target site recog-
nized by the RNP can be modified by finding other sites
compatible with RT recognition and then changing the
EBS/δ sequences of the intron as necessary to match the
new site [5]. Such retargeted mobile group II introns are
called ‘targetrons.’ Group II introns that have been made
into targetrons include both group IIA introns (Ll.LtrB
[7]) and group IIB introns (EcI5 [42] and RmInt1 [57]).
Group IIC introns are less appealing as candidates for
retargeting because they recognize hairpin structures via
as yet unknown mechanisms. The Ll.LtrB targetron is
commercially available through Sigma-Aldrich, and both
the Ll.LtrB and EcI5 targetrons are available through
Targetronics.
Although group II introns can and have been retar-
geted by the method mentioned above, in which the
closest match to the native recognition site in a se-
quence to be targeted is identified, and the base-pairing
sequences of the intron are modified to accommodate
discrepancies, the rules by which introns recognize their
target sites are actually more complex. For instance, the
RT recognizes different residues at the target site with
different stringencies, and none of these recognition
events are absolutely required for retrohoming to occur
[5,58,59]. If only the wild-type recognition sequence is
used, then new targeting sites may be hard to come by,
but knowing which bases can be varied and how is not a
simple matter. The EBS/δ sequences may also differ in
the stringency of required base-pairing interactions at
different positions. Algorithms have therefore been de-
veloped for retargeting the Ll.LtrB [7] and EcI5 [42]
introns. These algorithms were developed by examining
libraries of inserted mobile group II introns with ran-
domized base-pairing motifs for the most frequently
conserved residues and base-pairing interactions, and
using these frequencies to generate weighting schemes
for the various interactions. Potential target sites are
then assessed using the weighted criteria and assigned a
score. Although the algorithms have limitations and donot always correctly predict insertion frequency, typically
a targetron efficient enough to be screened for site-
specific insertion via colony PCR without selection can
be found for any given stretch of 1,000 base pairs of DNA.
Off-target integrations by the Ll.LtrB and EcI5 targetrons
are rare and can generally be avoided by the prudent step
of scanning the genome for closely matching target sites.
However, the specificity of targetrons could vary for differ-
ent target sites, making it important to confirm desired
single integrations by Southern hybridization.
The actual retargeting process is carried out by using
PCRs that modify the EBS/δ sequences within the intron
to base pair to the DNA target site and simultaneously
modify the IBS sequences upstream of the intron to base
pair to the retargeted EBS sequences to allow the intron
to splice out of a precursor RNA [6,7]. The PCR product
corresponding to a segment of the intron and upstream
exon is then cloned into a targetron expression vector
(see below). Alternatively, the entire region covering the
IBS1 and 2 and the EBS1, 2 and δ sequences can be
commercially synthesized in a single DNA molecule (for
example, as a gBlock sold by IDT) that can be cloned dir-
ectly into the vector [60]. The outlying δ’ or EBS3/IBS3
positions are typically adjusted by cloning the PCR prod-
uct into one of four parallel targetron vectors already
containing the correct bases for these interactions.
For biotechnological applications, targetrons are typic-
ally expressed from a donor plasmid that is transformed
or conjugated into the desired host (Figure 5A). In
E. coli, targetron donor plasmids have used a T7 pro-
moter driven by T7 RNA polymerase integrated into the
chromosome or expressed from a separate plasmid [6].
However, endogenous host or plasmid promoters can
also be used in E. coli and are commonly employed for
targetron expression in other bacteria [61-63]. A broad-
host-range targetron expression plasmid, pBL1, uses an
m-toluic acid-inducible promoter, which is not dependent
upon specific host factors for induction [64]. The typical
configuration for the targetron cassette is one in which
the ORF encoding the RT is removed from DIV of the
intron and expressed in tandem. This increases the ef-
ficiency of retrohoming and allows for disruptions of the
targeted gene to be either conditional or non-conditional,
depending on whether the intron is targeted to insert into
the sense or antisense strand of the gene and whether or
not the RT remains present to aid in splicing of the intron
from the mRNA (Figure 5B) [61,62].
It is also possible to select for targetron integration by
using a retrotransposition-activated marker (RAM) [59,63]
(Figure 6). This involves including in the targetron a se-
lectable marker, such as a kanR antibiotic-resistance gene,
that is inserted in the antisense orientation and is itself
disrupted by a self-splicing group I intron in the sense
orientation, a configuration first developed to detect rare
AB
Figure 5 Targetron donor plasmid and use of targetrons for conditional and non-conditional gene disruptions. (A) Targetron donor
plasmid. The plasmid expresses a modified group II intron with the reverse transcriptase (RT) ORF deleted (I-ΔORF) and flanked by short exons
under control of an active promoter (PA), which can be either inducible or constitutive. The RT ORF is expressed in tandem from a location just
downstream of E2. Protein-assisted splicing of the primary transcript produces a ribonucleoprotein (RNP) complex, which contains the group II
intron RT bound to the excised intron lariat RNA and which promotes site-specific integration of the intron into DNA target sites via retrohoming
(see Figure 3). (B) Use of targetrons for conditional and non-conditional gene disruptions. Conditional disruptions are obtained when the intron is
targeted to insert into the top or sense strand of the target gene. Transcription of the target gene from its own promoter in the host chromosome (PC)
results in a primary transcript from which the intron can be removed by providing the RT, which promotes protein-assisted RNA splicing. Non-conditional
disruptions are obtained by targeting of the intron to the bottom or antisense strand, which results in the insertion of the intron in an antisense orientation
relative to that of the target gene. Transcription of the target gene then yields a primary transcript containing the complement of the intron,
which is inactive and cannot be removed by RNA splicing.
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only be expressed after splicing out of the group I intron
and reverse transcription of the RNA intermediate into
DNA, as occurs during the process of retrohoming. An Ll.
LtrB targetron containing a trimethoprim-resistance-
RAM (TpR-RAM) and randomized EBS/δ sequences was
used to construct an E. coli gene disruption library [59].
After targetron expression, TpR colonies contained targe-
trons inserted into different genes with complementary
IBS/δ’ sequences, and these validated targetrons could be
recovered by simple PCR and used to obtain the same dis-
ruption in other E. coli strains [66], providing an alterna-
tive to the use of a targeting algorithm.
Targetron use in bacteria
Targetrons have been used in a wide range of bacteria,
including medically and commercially important speciesthat had been recalcitrant to gene targeting by other
methods (Table 1). Compared to other bacterial gene
targeting methods, advantages of targetrons are their
wide host range (the Ll.LtrB targetron works in virtually
all bacteria), ability to function in either RecA+ or RecA-
hosts, very high integration efficiencies (typically 1 to
100% without selection), and ease of retargeting via a
computer algorithm and simple PCR reactions that are
amenable to high-throughput approaches.
It is relatively simple to tailor the commercially avail-
able Ll.LtrB or EcI5 targetron cassettes for use in differ-
ent bacterial hosts. This typically requires re-cloning the
targetron cassette from the provided donor plasmid into
an established host-specific or broad-host-range expres-
sion plasmid with a strong promoter. Continuous targe-
tron expression, which can lead to off-target integrations,
can be avoided by using an inducible promoter or a donor
Figure 6 Use of a retrotranscription-activated marker (RAM) to
select for targetron integrations. A targetron with a RAM cassette
is expressed from a donor plasmid. The RAM cassette consists of a
selectable marker gene, such as an antibiotic-resistance gene (kanR),
inserted within the intron DIV in the antisense orientation, but
interrupted by an efficiently self-splicing group I intron (the phage
T4 td intron) in the sense orientation, thereby preventing expression of
the kanR marker gene from the donor plasmid. Transcription of the
targetron carrying the RAM from the donor plasmid yields a primary
transcript from which the group I intron is spliced to reconstitute the
kanR marker and the group II intron is spliced to yield RNPs that
retrohome into a DNA target site. After retrohoming, the reconstituted
kanR marker is expressed from its own promoter, enabling selection for
targetron integrations.
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A RAM capable of functioning in the desired bacteria
can also be introduced into the intron, but targeting fre-
quencies are typically high enough to screen for targetron
insertions by colony PCR, making such a marker dispens-
able. The ClosTron, which has made possible gene target-
ing in a wide range of notoriously difficult Clostridum spp.,
is a highly successful example of adaptation of the Ll.LtrB
targetron from a commercial kit [63,80], and similar adap-
tations of the Ll.LtrB targetron have been made for a var-
iety of other bacteria (for example, [62,64,71,81]). Because
the initial reverse splicing and target-DNA-primed reverse
transcription reactions are catalyzed by group II intron
RNPs, and because the late steps of second-strandsynthesis and cDNA integration are performed by com-
mon host factors [30,31,37,82,83], there are in principle no
limitations to the number of bacterial species in which
targetrons might function. As mobile group II introns are
present in the genomes of some archaea [84], it seems
likely that targetrons will prove useful in archaea, as well.
Applications of targetrons in bacteria
Targetrons have most frequently been used to generate
knock-outs in bacteria. A great deal of work has been
done using this method, with examples including identify-
ing virulence factors [70,72,74,85-88] and potential drug
targets [89,90], and examining the combinatorial effect of
different genomic loci on protein expression [91].
Targetrons have been particularly widely used in
strains of the genus Clostridium. Suicide plasmids were
previously the only method of utility in these strains
[63], but since Clostridia typically have very low trans-
formations frequencies (for instance, more than a milli-
gram of plasmid is required to transform Clostridium
acetobutylicum [92]), suicide plasmids are difficult to use
in these organisms. Targetrons have thus greatly in-
creased our understanding of and ability to engineer
Clostridia, many of which are of medical and industrial
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biofuel-producing strains, and targetrons have come into
frequent use to aid in understanding the metabolism of
these strains and to engineer them for higher yields
[92-110]. Targetron-mediated knockouts have been used
in a large number of studies on sporulation, germination,
and other aspects of the biology of Clostridium difficile, a
leading cause of diarrhea in hospitals [88,111-143]. Targe-
tron technology has also benefitted the study of toxin pro-
duction, sporulation, and other biological processes in
Clostridium botulinum [144-153], Clostridium perfringens
[69,85,154-164], and Clostridium sordellii [87,165]. Work
on developing targetrons for the thermophilic bacterium
Clostridium thermocellum is discussed in more detail
below.
Many bacteria of interest are difficult to transform due
to restriction-modification systems. In Staphylococcus
aureus [81], Clostridium acetobutylicum [166], and Clos-
tridium cellulolyticum [167], targetrons were used to
knock out restriction enzymes, thereby opening clinical
and environmental isolates to systematic mutational
analysis. Besides S. aureus and the Clostridium species
mentioned previously, targetrons have been developed
for use in other pathogenic bacteria, such as Francisella
tularensis [71], Bacillus anthracis [68,168], Listeria
monocytogenes [72], Pasteurella multocida [74], Vibrio
cholerae [78], and Ehrlichia chaffeensis [70], opening up
the possibility of using targetrons to develop vaccine
strains of these organisms.
Targetrons have also been used to deliver cargo genes,
including genes for fluorescent proteins [91], phage
resistance [61], and antigens for release into a host’s
digestive system as a live vaccine [169]. Unstructured
sequences of less than 100 nts in length can usually be
carried without impacting intron mobility. Longer se-
quences may impair functionality, and sequences above
1,000 nts can drastically decrease efficiency. DIV, par-
ticularly the DIVb loop, has been shown to be the best
location to insert cargo genes for minimal impact on
intron mobility [170]. Targetrons have also been used to
induce targeted genomic deletions via homologous re-
combination, albeit at much lower efficiencies than are
possible in tandem use with recombinases [171].
Finally, the relative simplicity of targetron retargeting,
combined with the falling costs of gene synthesis [172]
and the increasing ability to automate the laboratory
techniques involved [173,174], opens the door to high-
throughput construction of targetrons for simultaneous
integration into a multiplicity of loci. Applications could
include rapidly generating whole-genome knock-out li-
braries for novel organisms and testing in parallel differ-
ent combinations of mutants discovered in random
screens in order to, for example, improve the yield of a
target metabolite or develop a suitable vaccine strain fora pathogenic organism. Two other recent extensions of
targetron technology in bacteria are discussed below.
A thermotargetron for gene targeting in thermophiles
Bacterial thermophiles are widely used for the produc-
tion of chemicals and thermostable proteins but in many
cases have inefficient transformation systems and have
proven difficult to genetically engineer by conventional
methods relying on homologous recombination [175-177].
Recently, a thermotargetron for gene targeting in thermo-
philes was developed based on a group IIB intron (denoted
TeI3c) and RT (TeI4c RT) from the thermophilic
cyanobacterium Thermosynechococcus elongatus [178]
(Figure 7A; see also the diagram of the TeI4c RT in
Figure 2B). Unlike other group II introns that have been
made into targetrons, TeI3c is a naturally ORF-less group
II intron, and TeI4c is an RT that is encoded by another
group II intron but mobilizes TeI3c efficiently.
This TeI3c/4c thermotargetron was used for efficient
gene targeting in Clostridium thermocellum, an or-
ganism used in the consolidated bioprocessing of lig-
nocellulose biomass [178,179]. Like many species of
Clostridia, C. thermocellum has low, variable trans-
formation frequencies. An important feature of the
thermotargetron is its high integration efficiency, 67 to
100% without selection for seven successful gene dis-
ruptions, making it possible to identify disruptants by
colony PCR of only a small number of transformants.
Gene disruptions that block pathways leading to by-
products of cellulose degradation increased cellulolytic
ethanol production in C. thermocellum [178].
Another notable feature of the thermotargetron is that
it recognizes DNA target sites almost entirely by base
pairing of the intron RNA (11-bp), while the RT recog-
nizes only two bases (Figure 7B). The contribution of
the RT to DNA melting appears to be largely dispens-
able at higher temperatures. This feature is advantageous
because it increases the number of potential target sites
and should facilitate the targeting of short ORFs and
small non-coding RNAs, not only in thermophiles but also
potentially in mesophiles that can tolerate short times at
elevated temperatures (45 to 48°C). A downside of the
more limited protein recognition, however, is that it
decreases DNA target specificity, thus requiring greater
attention to targetron design to avoid integration into
closely matching off-target sites. The decreased target spe-
cificity may also contribute to the lower success rate for
gene disruptions (7 of 25 targetrons in initial tests), which
could be due in part to deleterious off-target integrations.
This situation should be ameliorated by the development
of algorithms to minimize off target integrations, as done
for other targetrons. The TeI3c/4c thermotargetron func-
tions in both Gram-negative and Gram-positive bacteria
and should be adaptable to a wide variety of thermophiles.
AB
Figure 7 Thermotargetron expression vector and DNA target
site recognition. (A) The thermotargetron expression vector
pHK-TTA1 carries replication origins for E. coli (ColE1 ori) and
Gram-positive bacteria (repB ori) and a chloramphenicol-resistance marker
gene (catR) that functions in both Gram-negative and Gram-positive
bacteria. The thermotargetron cassette consisting of the upstream
Thermosynechococcus elongatus TeI3c group IIB intron and the
downstream TeI4c RT is expressed from a Clostridium thermocellum
groEL promoter. (B) The figure shows DNA target site interactions
for the wild-type TeI3c group IIB intron used in the thermotargetron.
Portions of the intron RNA involved in EBS1-IBS1, EBS2-IBS2, and
EBS3-IBS3 base-pairings interactions with the DNA target site are
shown in red. Purple highlights indicate the two base-pairs in the 5’
exon (E1) that are important for DNA targeting and are likely recognized
by the TeI4c reverse transcriptase (RT). IS, intron-insertion site.
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Targetrons have recently been adapted for carrying lox
sites to facilitate large-scale genome engineering [60].
While recombinase sites have been previously included
in targetrons, they had rarely been used for any purpose
other than removing selectable markers after integration
[59,80]. Lox sites and other recombinase recognition
motifs with palindromic sequences can form stable hair-
pin structures upon transcription into RNA. In the ab-
sence of a selectable marker, such hairpin structures can
significantly impair the functionality of both the Ll.LtrB
and EcI5 targetrons. This effect was mitigated by adding
non-base-pairing regions to the base of the hairpin
structures, which presumably made the hairpins more
flexible, such that they no longer interfered with the
catalytic structures of the intron. These results point out
the importance of considering structure when designing
targetrons to carry cargo.
Since both targetrons and the Cre/lox system [180] func-
tion well in a wide variety of organisms, the combinationof both allows for a powerful and generalized genome
engineering system, where previously engineering solutions
typically needed to be developed for each organism. Once
the lox or other recombinase sites are positioned using the
targetrons, a variety of operations are possible. Figure 8
shows schematics for using the system to engineer large-
scale insertions, deletions, inversions, and one-step ‘cut-
and-paste’ operations in which large DNA segments are
translocated from one genomic site to another. Manipula-
tions of any size are possible, within the constraints of gene
content and genome structure. Among other manipula-
tions, the system was used to deliver a 12-kb polyketide
synthase operon to the genome of E. coli; move 100 kb of
the E. coli genome to another locus 1.5 Mb away; delete a
pathogenicity island from Staphylococcus aureus; and in-
vert approximately one third of the Bacillus subtilis gen-
ome. Intragenomic recombinations mediated by Cre-lox
occurred at essentially 100% efficiency, and intermolecular
recombinations occurred at 40 to 100% efficiency, without
the need to place any selectable markers in the genome.
The method can be expected to function in any organism
in which targetrons can be made to work.
These examples are likely but the first in a series of
innovations that will allow targetrons to be used for
large-scale genomic engineering. There are currently few
alternatives that allow the facile, site-specific introduction
of genetic material into microorganisms. While some or-
ganisms, such as Streptococcus pneumoniae [181] and
Acinetobacter [182], have relatively robust systems for
homologous recombination, most others do not. Simi-
larly, while methods such as recombineering [183,184]
and MAGE [174] have been developed that allow PCR
products and oligonucleotides to be readily introduced
into E. coli in a site-specific manner, these methods do
not scale to most other microorganisms. Targetrons are es-
sentially the only tool that can be used to site-specifically
‘punctuate’ the genomes of a wide array of bacteria, as has
previously been observed for recalcitrant thermophilic
strains and Clostridia, discussed elsewhere in this review.
While lox sites have been introduced to promote site-
specific recombination, the option also exists to introduce
a wide variety of other short genetic elements that can
impact phenotype, including promoters, terminators,
leader sequences, affinity tags, and even origins of replica-
tion. The use of targetron libraries [59,66] to seek out sites
that lead to improved functionality, combined with the use
of efficient targetron insertion to rapidly introduce multiple
targetrons into a single strain, either serially or in parallel,
makes targetrons the tool of choice for the engineering of
industrially-relevant microorganisms.
Prospects for targetron use in eukaryotes
Although efficient eukaryotic gene targeting technolo
gies have been developed, including Zn-finger nucleases,
Figure 8 Genome editing operations using targetrons and recombinases. Cre/lox is the recombinase system used in this example.
(A) Inserting exogenous DNA (recombinase-mediated cassette exchange). Two lox sites having incompatible linker regions and differing arm
mutations (for example, lox71 and lox66) are delivered to the genome using an intron. The sequence to be inserted is then delivered between lox
sites identical to those in the genome except having opposite arm mutations. The formation of non-functional lox sites (lox72) makes the process
irreversible. (B) Procedure for deleting genomic sequences. After delivery of lox sites (lox71 and lox66) on targetrons, Cre-mediated recombination
then deletes the intervening region, leaving a non-functional lox site (lox72) behind. (C) Procedure for inverting genomic sequences. The procedure is
the same as in panel B, except the lox sites have opposing orientations. (D) Procedure for one-step cut-and-paste after using introns to position lox
sites (two lox71 sites and one lox66 site) as shown. The first (reversible) step is Cre-mediated deletion, followed by Cre-mediated reinsertion at the target
site that is made irreversible by the formation of a non-functional lox site (lox72).
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the advantages of greater ease of retargeting than Zn-
finger nucleases or TALENS and potentially higher DNA
target specificity than any of the other methods. How-
ever, the barriers to targetron use in eukaryotes include
the requirement for delivering RNPs containing a large,
structured group II intron RNA to the nucleus, as well
as the relatively high Mg2+ concentrations required for
group II intron RNA function. Group II introns evolved
to function in bacteria, whose free Mg2+ concentrations
are generally 1 to 4 mM [185], whereas in eukaryotes,
Mg2+ concentrations are <1 mM and possibly lower in
nuclei, where Mg2+ is sequestered by binding to large
amounts of DNA [186,187]. These lower Mg2+ concen-
trations constitute a barrier to group II intron invasion
of nuclear genomes and limit their efficiency for gene
targeting in eukaryotes. Additional host defense and
innate immunity mechanisms could also come into play.
Initial studies showed that Ll.LtrB targetron RNPs
introduced into mammalian cells by transfection could
integrate into separately transfected plasmid target sites
albeit at low efficiency [5] and envisioned methods that
might be used for targeted repair of human genes [188].
In a later systematic study testing the feasibility of using
targetrons in eukaryotes, Ll.LtrB targetron RNPs were
microinjected directly into Xenopus laevis oocyte nuclei
and tested for retrohoming and gene targeting via double-
strand-break-stimulated homologous recombination in
plasmid assays [34]. These studies showed that retrohom-
ing and targeting via group II intron-stimulated homolo-
gous recombination occurred efficiently (up to 38% and
4.8% of plasmid target sites, respectively), but required
the injection of additional Mg2+, sufficient to obtain an
intracellular concentration of 5 to 10 mM. A similar re-
quirement for the injection of additional Mg2+ for retro-
homing was found for targetron RNPs injected into
Drosophila and zebrafish embryos [34]. Injection of tar-
getron RNPs plus Mg2+ have given targeted integration
into the chromosomal yellow gene in flies at frequencies
up to 0.12% in pooled embryos and 0.021% in pooled
adult files [189], and in X. laevis, a different approach,
using group II intron RNPs for site-specific DNA modifi-
cation in sperm nuclei followed by in vitro fertilization,
gave targeted integration at frequencies sufficiently high
to detect knockouts in a single copy mitF gene by PCR
screening of tail clippings (M Mastroianni, J Yao, and
AM Lambowitz, unpublished data). However, the fre-
quencies were variable and further improvements in
efficiency and reliability are needed for these to become
routine methods.
There is some prospect that more active group II in-
trons with enhanced retrohoming in eukaryotes can be
selected by directed evolution approaches. Recent work
showed that Ll.LtrB introns that retrohome more efficientlyat lower Mg2+ could be selected in an E. coli mutant de-
ficient in Mg2+-transport [190], laying the groundwork
for direct selections of group II introns that function
more efficiently in eukaryotic cells. The recent group II
intron RNA X-ray crystal structures [19-21] may also
enable rational design approaches to enhancing group II
intron function. If these efforts prove successful, the
same rationales that are driving the use of targetrons for
genomic engineering in bacteria will extend to genomic
engineering in eukaryotes.
Thermostable group II intron reverse transcriptases
Reverse transcriptases are widely used in biotechnology
for applications involving cDNA synthesis, such as qRT-
PCR and RNA-seq. Most if not all of these applications
would benefit from using RTs that synthesize cDNAs
with high processivity and fidelity. However, the retro-
viral RTs that are commonly used for these methods
have inherently low fidelity and processivity, reflecting
that these enzymes evolved to help retroviruses evade
host defenses by introducing sequence variations and
rapidly propagating successful ones by RNA recombin-
ation [191]. Vast sums have been expended to engineer
variants of retroviral RTs that overcome these inherent
deficiencies.
By contrast, group II intron RTs evolved to have high
processivity and fidelity, reflecting their function in
retrohoming, which requires synthesis of an accurate,
full-length cDNA copy of a highly structured group II
intron RNA [8,9]. Other advantageous characteristics
of group II intron RTs are their lack of RNase H activ-
ity, which enables reuse of RNA templates, and their
difficulty in initiating on DNA templates, which pre-
serves RNA strand information by minimizing recopy-
ing of cDNAs [23,31].
In a recent technical advance that makes group II intron
RTs available for widespread use as tools for research and
biotechnology, general methods were developed that en-
able their high-level expression in bacteria and their purifi-
cation in active form free of tightly bound RNA [10].
These methods involve the expression of group II intron
RTs as fusion proteins with a solubility tag, such as MalE
or NusA, attached to the N-terminus of the RT via a non-
cleavable rigid linker (Figure 9). The attached solubility
tag enables the protein to remain soluble when freed of
the intron RNA, and the rigid linker minimizes inter-
ference of the tag with RT function.
By applying the above methods to group II intron RTs
from the bacterial thermophiles Thermosynechococcus
elongatus and Geobacillus stearothermophilus (Figure 2B),
it was possible to obtain thermostable group II intron RT
fusion proteins that synthesize cDNAs at temperatures up
to 81°C with much higher processivity and two- to four-
fold higher fidelity than retroviral RTs [10]. The high
Figure 9 Thermostable group II intron reverse transcriptase
(RT) fusion proteins. High-level expression of thermostable group II
intron RTs that remain soluble when purified free of bound RNAs is
achieved by expressing the RT as a fusion protein with a solubility
tag, such as MalE or NusA, linked to the N-terminus of the RT via a
non-cleavable rigid linker [10]. In these examples, the rigid linker
consists of five alanine residues and the MalE and NusA tags are
modified (MalE, charged amino acids changed to alanines (italics);
NusA, two C-terminal amino acids deleted) to reduce conformational
flexibility at the fusion junction and achieve an optimal spacing
between the solubility tag and the group II intron RT [10].
Figure 10 Thermostable group II intron reverse transcriptase
(RT) template switching method for attachment of adaptor
sequences for RNA-seq. The RT binds to an initial substrate consisting
of a synthetic RNA oligonucleotide adaptor and an annealed DNA
primer, with the RNA oligonucleotide having a blocking group attached
to its 3’ end to impede recopying by the RT. In the example shown, the
initial substrate has a single nucleotide 3’ overhang of the DNA primer
(denoted N to signify that this nucleotide can be A, C, G, or T or a
mixture of all four nucleotides). The single nucleotide 3’ overhang can
facilitate template switching by base pairing to a complementary 3’
terminal nucleotide of a target RNA, which is a miRNA in the example
shown. After template switching, the RT copies the target miRNA. The
resulting cDNA containing the adaptor sequence seamlessly linked to
the miRNA sequence is circularized with CircLigase and amplified by PCR
with Primers P1 and P2 that introduce primer-binding sites and barcodes
for RNA-seq. Relinearization of the circularized cDNA, which can increase
the efficiency of the PCR in some cases, is an optional step [10].
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synthesizing long cDNAs that preserve information about
alternatively spliced RNAs and for RNA footprinting and
structure mapping using RNA modification reagents,
where premature terminations by retroviral RTs at un-
modified sites result in high background and loss of infor-
mation. The higher fidelity of group II intron RT should
benefit applications, such as tumor profiling, that require
the analysis of sequence variants.
We are still at the early stages of developing methods
and applications utilizing the novel properties of these
enzymes. Group II intron RTs behave differently from
retroviral RTs, both in terms of optimal conditions for
different applications and their tighter binding to nucleic
acids, which necessitates different types of clean-up pro-
cedures for cDNA products. Consequently, group II in-
tron RTs cannot simply be substituted into protocols
developed for retroviral RTs and must be optimized for
each application. In a published application, a thermo-
stable group II intron RT was used to generate RNA-seq
libraries of human mRNAs, using an oligo(dT)42 primer
[10]. The resulting libraries showed relatively uniform 5’
to 3’ coverage of all size classes of human mRNAs, in-
cluding those >7 kb, whereas parallel libraries prepared
using the thermostable retroviral RT, SuperScript III,
showed a strong bias for reads near the 3’ ends of
mRNAs, reflecting premature terminations. The ability
to obtain RNA-seq libraries with uniform 5’ to 3’ cover-
age using an oligo(dT) primer avoids steps such as ribo-
depletion and RNA fragmentation, which are needed to
minimize rRNA contamination and obtain uniform
coverage in libraries prepared using retroviral RTs. The
minimal manipulation needed to prepare whole cell
RNA-seq libraries using group II intron RTs may be use-
ful for procedures that start with small amounts of
RNA, such as transcriptome analysis from single cells.In addition to their higher processivity and fidelity
than retroviral RTs, group II intron RTs have a novel
end-to-end template switching activity in which the RT
synthesizes a cDNA copy of one template and then
switches directly to the 3’ end of a second template [10].
As illustrated in Figure 10, this template-switching ac-
tivity can be used to seamlessly link RNA-seq adaptor
sequences containing primer-binding sites and barcodes
to cDNAs during reverse transcription, thereby avoiding
an additional inefficient and bias-inducing step of using
RNA ligase for linker ligation. In the example shown,
the group II intron RT initiates from a short synthetic
RNA oligonucleotide adaptor with an annealed DNA
primer. It then switches to the 3’ end of a target
miRNA, yielding a continuous cDNA containing the
RNA-seq adaptor sequence seamlessly linked to the
miRNA sequence.
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tron RTs are prone to add extra non-templated nucleo-
tides to DNA upon reaching the end of an RNA
template (ref. [10] and references therein), which could
lead to non-seamless junctions and biases during tem-
plate switching. This problem is avoided by using an ini-
tial template/primer substrate consisting of a synthetic
RNA oligonucleotide annealed to a DNA primer that
leaves a single nucleotide 3’ overhang. This 3’ overhang
nucleotide base pairs with the 3’ terminal nucleotide of
the second RNA template, resulting in a seamless switch
to the second template. A specific 3’ overhang nucleo-
tide can be used to direct the RT to a specific target
RNA, while a mixture of 3’ overhang nucleotides is used
to minimize bias for mixtures of templates having differ-
ent 3’ RNA ends.
After template switching, the resulting cDNA linked
to adapter sequences is circularized with CircLigase and
PCR amplified to generate an RNA-seq library (Figure 10).
By incorporating an additional step for removal of a 3’
phosphate of the target RNAs, the method can also
be applied to protein- and ribosome-bound RNA frag-
ments in procedures such as HITS-CLIP, CRAC, RIP-
Seq, and ribosome profiling. Because thermostable
group II intron RTs can template-switch to RNAs with
modified 3’ ends and reverse transcribe through highly
structured RNAs, the method can potentially lead
to the identification of novel miRNAs and other non-
coding RNAs that cannot be cloned by current
methods using retroviral RTs.
Conclusions
The biotechnological applications of mobile group II
introns and their RTs are an example of how basic re-
search into biochemical mechanisms and evolution can
lead to unexpected practical applications. Targetrons,
which arose from studies of the mechanism of group II
intron mobility, now provide a broad-host-range solu-
tion to knock-outs and, when combined with other tech-
nologies, such as site-specific recombinases, can be
employed to make a wide variety of changes in almost
any bacteria, including previously recalcitrant medically
and industrially important species. Together with the
prospect of targetron-mediated mutagenesis in archaea
and the possibility of adapting targetrons for use in
eukaryotes, targetrons are well-positioned to play an
expanding role in the analysis and engineering of ge-
nomes for biotechnological and medical applications.
The unique properties of group II RTs, enzymes that
were discovered solely as a consequence of basic re-
search, may ameliorate many of the problems of current
in vitro methodologies for RNA analysis, qRT-PCR, and
RNA-seq, with potentially wide applications in biomed-
ical research, diagnostics, and biotechnology.Abbreviations
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